scispace - formally typeset
S

Scott W. Hiebert

Researcher at Vanderbilt University

Publications -  182
Citations -  22342

Scott W. Hiebert is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Transcription factor & Fusion protein. The author has an hindex of 73, co-authored 176 publications receiving 21184 citations. Previous affiliations of Scott W. Hiebert include Vanderbilt University Medical Center & Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis

TL;DR: The results suggest that AML1-regulated target genes are essential for definitive hematopoiesis of all lineages, and that this defect was intrinsic to the stem cells in that AMl1-/-ES cells failed to contribute to hematocerosis in chimeric animals.
Journal ArticleDOI

The E2F transcription factor is a cellular target for the RB protein.

TL;DR: The results suggest that the interaction of RB with E2F is an important event in the control of cellular proliferation and that the dissociation of the complex is part of the mechanism by which E1A inactivates RB function.
Journal ArticleDOI

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

TL;DR: The product (pRb) of the retinoblastoma gene (RB-1) prevents S-phase entry during the cell cycle, and inactivation of this growth-suppressive function is presumed to result from pRb hyperphosphorylation during late G1 phase.
Journal ArticleDOI

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

TL;DR: The cloning of a t(12;21) translocation breakpoint involving 12p13 and 21q22 in two cases of childhood pre-B acute lymphoblastic leukemia shows that TEL, previously shown to be fused to the platelet-derived growth factor receptor beta in chronic myelomonocytic leukemia, can be implicated in the pathogenesis of leukemia through its fusion to either a receptor tyrosine kinase or a transcription factor.
Journal ArticleDOI

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

TL;DR: Assays of transcription from the adenovirus E2 promoter in transfection experiments demonstrate that formation of the complex containing pRB and E2F coincides with an inhibition of E 2F-dependent transcriptional activity.